THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 122 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $64,354,428 | -16.6% | 7,457,060 | 0.0% | 3.81% | -35.6% |
| Q2 2023 | $77,180,571 | -4.6% | 7,457,060 | 0.0% | 5.92% | +14.3% |
| Q1 2023 | $80,909,101 | -3.3% | 7,457,060 | 0.0% | 5.18% | +51.9% |
| Q4 2022 | $83,668,213 | +10.7% | 7,457,060 | 0.0% | 3.41% | +83.4% |
| Q3 2022 | $75,615,000 | +33.8% | 7,457,060 | +19.6% | 1.86% | +34.6% |
| Q2 2022 | $56,511,000 | +9.2% | 6,237,438 | +15.2% | 1.38% | +28.6% |
| Q1 2022 | $51,743,000 | +80.0% | 5,412,487 | +108.0% | 1.07% | +74.2% |
| Q4 2021 | $28,750,000 | – | 2,601,778 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 10,898,879 | $264,297,000 | 23.51% |
| Foundation Asset Management, LP | 399,537 | $9,689,000 | 3.59% |
| Cormorant Asset Management, LP | 1,300,000 | $31,525,000 | 2.35% |
| Baupost Group | 9,309,168 | $225,747,000 | 2.18% |
| Old West Investment Management, LLC | 109,320 | $2,651,000 | 1.53% |
| SENZAR ASSET MANAGEMENT, LLC | 187,856 | $4,555,000 | 1.44% |
| Chescapmanager LLC | 350,631 | $8,503,000 | 1.27% |
| Virtus ETF Advisers LLC | 32,989 | $800,000 | 0.69% |
| Rock Springs Capital Management LP | 652,600 | $15,826,000 | 0.68% |
| NJ State Employees Deferred Compensation Plan | 34,142 | $828,000 | 0.15% |